Skip to content
FIND A BIOALPS ACTOR

Actor

MaxiVAX

Share this actor

Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine GmbH (“Minaris”), a leading contract development and manufacturing service provider for the cell and gene therapy industry, have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of cancers such as chordoma, head and neck, and other solid tumors

Specialties

Primary Therapeutic Areas

0. COVID-19

1.0 Therapeutic & Diagnostic

1.00 Antibodies & Anti-infectious

1.02 Cell Therapy & Stem Cell

1.05 Gene Therapy

1.10 Small Molecules

1.11 Vaccine

Business model

1. Entreprise

1.2 Scale-Up

Organization Type

Private Company

MaxiVAX

Visit website

Domains

Immunology & Allergy, Oncology, Vaccine

Main sector

Biotech

Contact

Avenue de Sécheron 15
1202 Geneva / GE
+41 22 552 26 13

contact@maxivax.ch